Stock Research for AVXL

AVXL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AVXL Stock Chart & Research Data

The AVXL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AVXL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AVXL Due diligence Resources & Stock Charts

The AVXL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AVXL Detailed Price Forecast - CNN Money CNN View AVXL Detailed Summary - Google Finance
Yahoo View AVXL Detailed Summary - Yahoo! Finance Zacks View AVXL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AVXL Trends & Analysis - Trade-Ideas Barrons View AVXL Major Holders - Barrons
NASDAQ View AVXL Call Transcripts - NASDAQ Seeking View AVXL Breaking News & Analysis - Seeking Alpha
Spotlight View AVXL Annual Report - CompanySpotlight.com OTC Report View AVXL OTC Short Report - OTCShortReport.com
TradeKing View AVXL Fundamentals - TradeKing Charts View AVXL SEC Filings - Bar Chart
WSJ View Historical Prices for AVXL - The WSJ Morningstar View Performance/Total Return for AVXL - Morningstar
MarketWatch View the Analyst Estimates for AVXL - MarketWatch CNBC View the Earnings History for AVXL - CNBC
StockMarketWatch View the AVXL Earnings - StockMarketWatch MacroAxis View AVXL Buy or Sell Recommendations - MacroAxis
Bullish View the AVXL Bullish Patterns - American Bulls Short Pains View AVXL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AVXL Stock Mentions - StockTwits PennyStocks View AVXL Stock Mentions - PennyStockTweets
Twitter View AVXL Stock Mentions - Twitter Invest Hub View AVXL Investment Forum News - Investor Hub
Yahoo View AVXL Stock Mentions - Yahoo! Message Board Seeking Alpha View AVXL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AVXL - SECform4.com Insider Cow View Insider Transactions for AVXL - Insider Cow
CNBC View AVXL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AVXL - OTC Markets
Yahoo View Insider Transactions for AVXL - Yahoo! Finance NASDAQ View Institutional Holdings for AVXL - NASDAQ


Stock Charts

FinViz View AVXL Stock Insight & Charts - FinViz.com StockCharts View AVXL Investment Charts - StockCharts.com
BarChart View AVXL Stock Overview & Charts - BarChart Trading View View AVXL User Generated Charts - Trading View




Latest Financial News for AVXL


Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Posted on Monday March 25, 2024

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference, April


Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
Posted on Monday March 18, 2024

First patient screened ahead of schedule Trial to investigate positive, negative, and cognitive domains of schizophrenia ANAVEX®3-71’s differentiated dual novel mechanism of action offers the potential to synergistically activate both SIGMAR1 and M1 muscarinic receptors and treat all symptom domains of schizophrenia without the side effects of standard of care antipsychotics NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clin


12 $10 Stocks That Will Triple
Posted on Monday February 26, 2024

In this article, we discuss 12 $10 stocks that will triple. If you want to skip our discussion on the latest stock market landscape, head over to 5 $10 Stocks That Will Triple. According to JPMorgan, the global outlook for securities markets in 2024 suggests a more positive scenario compared to the previous year, with […]


Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
Posted on Monday February 26, 2024

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced that it will present at the 44th Annual TD Cowen Health Care Conference, March 4-6, 2


Stock Market & Investing Books

Enter a stock symbol to view the stock details.